載入...
Intracellular targeting with engineered proteins
If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated...
Na minha lista:
| 發表在: | F1000Res |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
F1000Research
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4984483/ https://ncbi.nlm.nih.gov/pubmed/27547383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8915.1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|